Stock GYRE GYRE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Gyre Therapeutics, Inc.

Equities

GYRE

US4037831033

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-06-13 pm EDT 		5-day change 1st Jan Change
11.04 USD 0.00% Intraday chart for Gyre Therapeutics, Inc. +2.32% -57.03%
May. 31 Gyre Therapeutics Gets Investigational New Drug Application Approval in China for Pulmonary Arterial Hypertension Therapy MT
May. 30 Gyre Pharmaceuticals Receives IND Approval from China?s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
GL
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
GL
Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes
GL
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GL
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
AQ
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
GL
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
GL
Totus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B Funding
PR
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
GL
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GYRE Stock
  4. News Gyre Therapeutics, Inc.
  5. Press Releases